Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Colorcon
McKinsey
Baxter
McKesson
Johnson and Johnson

Last Updated: October 20, 2019

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 021142

See Plans and Pricing

« Back to Dashboard

NDA 021142 describes OLUX, which is a drug marketed by Mylan and is included in two NDAs. It is available from three suppliers. There are four patents protecting this drug and two Paragraph IV challenges. Additional details are available on the OLUX profile page.

The generic ingredient in OLUX is clobetasol propionate. There are fourteen drug master file entries for this compound. Forty-seven suppliers are listed for this compound. Additional details are available on the clobetasol propionate profile page.
Summary for 021142
Tradename:OLUX
Applicant:Mylan
Ingredient:clobetasol propionate
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 021142
Medical Subject Heading (MeSH) Categories for 021142
Suppliers and Packaging for NDA: 021142
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
OLUX clobetasol propionate AEROSOL, FOAM;TOPICAL 021142 NDA AUTHORIZED GENERIC Mylan Pharmaceuticals Inc. 0378-8167 0378-8167-01 100 g in 1 CAN (0378-8167-01)
OLUX clobetasol propionate AEROSOL, FOAM;TOPICAL 021142 NDA AUTHORIZED GENERIC Mylan Pharmaceuticals Inc. 0378-8167 0378-8167-50 50 g in 1 CAN (0378-8167-50)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:AEROSOL, FOAM;TOPICALStrength0.05%
Approval Date:May 26, 2000TE:AB1RLD:Yes

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
McKesson
McKinsey
Harvard Business School
Johnson and Johnson
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.